OHSU

Institutional Biosafety Committee (IBC)

The IBC is posting the following new and revised documents for use:


The NIH Guidelines Involving Recombinant or Synthetic Nucleic Acid Molecules, defines these nucleic acid molecules as:

(i) molecules that (a) are constructed by joining nucleic acid molecules and b) that can replicate in a living cell, i.e., recombinant nucleic acids;
(ii) nucleic acid molecules that are chemically or by other means synthesized or amplified, including those that are chemically or otherwise modified but can base pair with naturally occurring nucleic acid molecules, i.e. synthetic nucleic acids, or
(iii) molecules that result from the replication of those described in (i) or (ii) above.

Infectious Agents are generally defined as risk group 2 agents and above (agents that can cause disease in healthy adult humans).

Use of Biologically Derived Toxins need only be reviewed by the IBC if the toxin is a select agent, or if the toxin is lethal for vertebrates at an LD50 of less than 100 nanograms per kilogram body weight.

Contact Us

at or call 503-494-7887 (option 1) or visit the Research Safety Team page.

baker

Check out the new and revised viral vector tables, which now includes information on biosafety levels required for different uses of lentiviral vectors.

Want news and policy updates from our office?

 

Email us to join the IBC listserv.

 

suggestion box-ORIO-150px